Consolidated statement of changes in equity
| Attributable to holders of the parent | ||||||||||||||
| Non-distributable reserves | ||||||||||||||
| Notes | Issued share capital R'000 |
Share premium R'000 |
Continuing operations R'000 |
Discontinued operations held-for-sale R'000 |
Retained income R'000 |
Total attributable to ordinary share- holders R'000 |
Non- controlling interests R'000 |
Total R'000 |
||||||
| As at 1 July 2014 | 16 878 | 510 920 | 426 415 | 1 784 688 | 2 738 901 | 118 578 | 2 857 479 | |||||||
| Share issue | 18, 19 | 10 | 2 018 | 2 028 | 2 028 | |||||||||
| Movement in share-based payment reserve | 20 | 16 098 | 16 098 | 16 098 | ||||||||||
| Acquisition of non-controlling interests in Ayrton Drug Manufacturing Limited | 1.2 | (31) | (31) | (101) | (132) | |||||||||
| Total comprehensive income | 62 487 | 197 932 | 260 419 | (330) | 260 089 | |||||||||
| Profit for the year | 197 932 | 197 932 | 877 | 198 809 | ||||||||||
| Other comprehensive income | 62 487 | 62 487 | (1 207) | 61 280 | ||||||||||
| Disposal of non-controlling | ||||||||||||||
| interest in Bioswiss Proprietary | ||||||||||||||
| Limited | 1.1 | (14 101) | (14 101) | |||||||||||
| Dividends | 9.1 | (4 537) | (4 537) | |||||||||||
| Balance at 30 June 2015 | 16 888 | 512 938 | 505 000 | 1 982 589 | 3 017 415 | 99 509 | 3 116 924 | |||||||
| Share issue | 18, 19 | 1 | 189 | 190 | 190 | |||||||||
| Movement in share-based payment reserve | 20 | 12 578 | 12 578 | 12 578 | ||||||||||
| Transfer to discontinued operations | (58 200) | 58 200 | ||||||||||||
| Implementation of BEE scheme | 258 | 153 746 | (44 587) | 109 417 | (79 883) | 29 534 | ||||||||
| Acquisition of non-controlling interests in Ayrton Drug Manufacturing Limited | 1.2 | (1) | (1) | (1) | (2) | |||||||||
| Total comprehensive income | 24 137 | 86 798 | 168 801 | 279 736 | 12 614 | 292 350 | ||||||||
| Profit for the year | 168 801 | 168 801 | 10 341 | 179 142 | ||||||||||
| Other comprehensive income | 24 137 | 86 798 | 110 935 | 2 273 | 113 208 | |||||||||
| Dividends | 9.1 | (190 762) | (190 762) | (6 215) | (196 977) | |||||||||
| Balance at 30 June 2016 | 17 147 | 666 873 | 483 515 | 144 998 | 1 916 040 | 3 228 573 | 26 024 | 3 254 597 | ||||||